Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
AbbVie IncABBV84.016.39107.0423.7262.29%10.76%0.00$197.36$1,803.44265,796$203.985

Detail of AbbVie Inc

 
CEO
Mr. Robert A. Michael CPA
Employees
55000
Industry
Drug Manufacturers - General
Sector
Healthcare
Market cap
$360B

Company details

AbbVie Inc. is a prominent biopharmaceutical company that focuses on developing innovative therapies addressing some of the world's most challenging diseases. Originating from a 2013 spinoff of Abbott Laboratories, AbbVie is dedicated to the research and production of pharmaceutical products designed to improve patient outcomes globally. With a robust portfolio, the company specializes in treatments for autoimmune conditions, infectious diseases, oncology, and ophthalmology. Among its flagship products is Humira, widely used for rheumatoid arthritis and inflammatory conditions, which has established AbbVie as a leader in this therapeutic area. The company also invests heavily in research and development, resulting in a pipeline of promising drugs designed to cater to unmet medical needs. AbbVie operates in North America and international markets, serving healthcare providers, researchers, and patients. Its commitment to scientific innovation and high-quality manufacturing standards has positioned it as an influential entity in the healthcare and pharmaceuticals sector.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$56.33B
Cost of goods (CoG)
-$16.90B
Gross profit (GP)
$39.43B
Operating expense (OE)
-$27.54B
Research and development (R&D)
-$12.79B
General and administrative (G&A)
-$14.75B
Operating income (OI)
$11.89B
Other income expense (OIE)
-$6.02B
Pretax income (PI)
$3.72B
Tax (TAX)
$570.00M
Net income (NI)
$4.29B
AbbVie Inc
ABBV • XNYS • US
$203.985
+26.58 (14.97%)
Stock vs Industry average
  • Industry average

Dividend yield
3.08%
Trailing annual dividend rate
$6.38
Payout ratio
259.41%
EPS
$2.43
Margin profit
7.59%
52 week low
$154.789993
52 week high
$205.470001
50-day simple moving average
$199.56
200-day simple moving average
$197.36
Percent held by insiders
0.50%
Percent held by institutions
73.96%
Dividend yield
3.16%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
ABBV +14.36%
eps change
ABBV -102.68%